Sandra T. van Tiel

1.8k citations

53 papers · 1.4k indexed · h-index 22

Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 6
Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 7
Oncology top 10%
Cancer Research top 10%
Immunology top 10%
- Immunotherapy and Immune Responses 10
Molecular Biology
- Angiogenesis and VEGF in Cancer 10
- RNA Interference and Gene Delivery 7
Pulmonary and Respiratory Medicine
- Sarcoma Diagnosis and Treatment 10
Genetics
- Virus-based gene therapy research 7
Radiology, Nuclear Medicine and Imaging
- Advanced MRI Techniques and Applications 5

Co-authors: Timo L.M. ten Hagen Ann L.B. Seynhaeve A.M.M. Eggermont Johannes H. W. de Wilt Alexander M.M. Eggermont E. A. de Bruijn Alexander Eggermont Monique R. Bernsen
Cited by: Biomaterials Immunology and Allergy Oncology
Journals: PLoS ONE (3 papers)JNCI Journal of the National Cancer Institute (1 paper)Cancer Research (2 papers)
Partner nations: Netherlands Belgium Spain

In The Last Decade

Sandra T. van Tiel

53 papers receiving 1.4k citations

Peers

Countries citing papers authored by Sandra T. van Tiel

Since Specialization

Citations

This map shows the geographic impact of Sandra T. van Tiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra T. van Tiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra T. van Tiel more than expected).

Fields of papers citing papers by Sandra T. van Tiel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra T. van Tiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra T. van Tiel. The network helps show where Sandra T. van Tiel may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sandra T. van Tiel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sandra T. van Tiel Line = papers co-authored together Sandra T. van Tiel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Peripheral blood monocyte and synovial macrophage subsets in the mouse model of osteoarthritis induced by destabilization of the medial meniscus Osteoarthritis and Cartilage ·Lizette Utomo,Niamh Fahy,Nicole Kops,Sandra T. van Tiel,J.H. Waarsing,Jan A.N. Verhaar,Pieter J. M. Leenen,Gerjo J. V. M. van Osch,Y.M. Bastiaansen-Jenniskens	2019	1
2	In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer Molecular Imaging and Biology ·Ingrid L. Bakker,Sandra T. van Tiel,Joost Haeck,Gabriela N. Doeswijk,Erik de Blois,Marcel Segbers,Θεοδοσία Μάινα,Berthold A. Nock,Marion de Jong,Simone U. Dalm	2018	14
3	SPIO labeling of endothelial cells using ultrasound and targeted microbubbles at diagnostic pressures PLoS ONE ·Ilya Skachkov,Ying Luan,Sandra T. van Tiel,Antonius F.W. van der Steen,Nico de Jong,Monique R. Bernsen,Klazina Kooiman	2018	3
4	Imaging inflammation in the knee joint with 111IN-octreoscan Osteoarthritis and Cartilage ·Sandra T. van Tiel,Lizette Utomo,Jan de Swart,M. de Jong,Monique R. Bernsen,Y.M. Bastiaansen-Jenniskens	2016	2
5	Nanoparticles and clinically applicable cell tracking British Journal of Radiology ·Monique R. Bernsen,Jamal Guenoun,Sandra T. van Tiel,Gabriël P. Krestin	2015	29
6	Magnetic Resonance Detection of CD34+ Cells from Umbilical Cord Blood Using a 19F Label PLoS ONE ·Lucia Duinhouwer,Bernard J. M. van Rossum,Sandra T. van Tiel,Ramon M. van der Werf,Gabriela N. Doeswijk,Joost Haeck,Elwin W. J. C. Rombouts,Mariëtte N. D. ter Borg,Gyula Kotek,Eric Braakman,Jan J. Cornelissen,Monique R. Bernsen	2015	7
7	Basal cell carcinomas without histological confirmation and their treatment: an audit in four European regions British Journal of Dermatology ·S.C. Flohil,Charlotte M. Proby,Alasdair Forrest,Sandra T. van Tiel,Olli Saksela,Sari Pitkänen,T. Ahti,R. Micallef,Esther de Vries,(unknown)	2012	17
8	Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo Biochemical and Biophysical Research Communications ·Eric Farrell,Piotr A. Wielopolski,P. Pavljasevic,Sandra T. van Tiel,Holger Jahr,Jan A.N. Verhaar,Harrie Weinans,Gabriël P. Krestin,Fergal J. O’Brien,Gerjo van Osch,Monique R. Bernsen	2008	119
9	Tumor Necrosis Factor α Mediates Homogeneous Distribution of Liposomes in Murine Melanoma that Contributes to a Better Tumor Response Cancer Research ·Ann L.B. Seynhaeve,Saske Hoving,Debby Schipper,Cindy E. Vermeulen,Gisela aan de Wiel‐Ambagtsheer,Sandra T. van Tiel,Alexander Eggermont,Timo L.M. ten Hagen	2007	142
10	Early destruction of tumor vasculature in tumor necrosis factor-α-based isolated limb perfusion is responsible for tumor response Anti-Cancer Drugs ·Saske Hoving,Ann L.B. Seynhaeve,Sandra T. van Tiel,Gisela aan de Wiel‐Ambagtsheer,E. A. de Bruijn,Alexander Eggermont,Timo L.M. ten Hagen	2006	30
11	Gene Therapy in In Vivo Isolated Perfusion Models Current Gene Therapy ·Boudewijn van Etten,Alexander M.M. Eggermont,Sandra T. van Tiel,Gisela Ambagtsheer,Johannes H.W. de Wilt,Timo Hagen	2005	9
12	Dynamic contrast-enhanced MRI using macromolecular contrast media for monitoring the response to isolated limb perfusion in experimental soft-tissue sarcomas Magnetic Resonance Materials in Physics Biology and Medicine ·Adrian Preda,Piotr A. Wielopolski,Timo L.M. ten Hagen,M. van Vliet,Jifke F. Veenland,Gisela Ambagtsheer,Sandra T. van Tiel,Mika W. Vogel,Alexander M.M. Eggermont,Gabriël P. Krestin,Cornelis F. van Dijke	2004	17
13	Synergistic Antitumor Activity of Histamine Plus Melphalan in Isolated Limb Perfusion: Preclinical Studies JNCI Journal of the National Cancer Institute ·Flávia Brunstein,Saske Hoving,Ann L.B. Seynhaeve,Sandra T. van Tiel,G. Guetens,E. A. de Bruijn,Alexander M.M. Eggermont,Timo L.M. ten Hagen	2004	32
14	Tumor necrosis factor‐α augmented tumor response in B16BL6 melanoma‐bearing mice treated with stealth liposomal doxorubicin (Doxil®) correlates with altered Doxil® pharmacokinetics International Journal of Cancer ·Peter Brouckaert,Nozomi Takahashi,Sandra T. van Tiel,Jeroen Hostens,Alexander Eggermont,Ann L.B. Seynhaeve,Walter Fiers,Timo L.M. ten Hagen	2004	42
15	Lack of efficacy of Doxil® in TNF-α-based isolated limb perfusion in sarcoma-bearing rats British Journal of Cancer ·Timo L.M. ten Hagen,Saske Hoving,Gisela Ambagtsheer,Sandra T. van Tiel,A.M.M. Eggermont	2004	3
16	Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF-α-based isolated hepatic perfusion British Journal of Cancer ·Boudewijn van Etten,Mark R. de Vries,Marc G. A. van Ijken,Titia E. Lans,G. Guetens,Gisela Ambagtsheer,Sandra T. van Tiel,Gert De Boeck,E. A. de Bruijn,Alexander M.M. Eggermont,Timo L.M. ten Hagen	2003	39
17	Isolated limb perfusion with actinomycin D and TNF-alpha results in improved tumour response in soft-tissue sarcoma-bearing rats but is accompanied by severe local toxicity British Journal of Cancer ·Ann L.B. Seynhaeve,Johannes H. W. de Wilt,Sandra T. van Tiel,A.M.M. Eggermont,Timo L.M. ten Hagen	2002	23
18	Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions British Journal of Cancer ·Johannes H. W. de Wilt,Eric R. Manusama,Boudewijn van Etten,Sandra T. van Tiel,Anita S. Jorna,Ann L.B. Seynhaeve,Timo L.M. ten Hagen	2000	40
19	Low-dose tumor necrosis factor-α augments antitumor activity of stealth liposomal doxorubicin (DOXIL®) in soft tissue sarcoma-bearing rats International Journal of Cancer ·Timo L.M. ten Hagen,A.H. van der Veen,Peet Nooijen,Sandra T. van Tiel,Ann L.B. Seynhaeve,Alexander Eggermont	2000	67
20	TNF- α augments intratumoural concentrations of doxorubicin in TNF- α -based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects British Journal of Cancer ·A.H. van der Veen,Johannes H. W. de Wilt,A.M.M. Eggermont,Sandra T. van Tiel,Ann L.B. Seynhaeve,Timo L.M. ten Hagen	2000	123

About Sandra T. van Tiel

Sandra T. van Tiel is a scholar working on Immunology and Allergy, Immunology and Hematology, having authored 53 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), Angiogenesis and VEGF in Cancer (10 papers), Sarcoma Diagnosis and Treatment (10 papers), Virus-based gene therapy research (7 papers), RNA Interference and Gene Delivery (7 papers), Cell Adhesion Molecules Research (7 papers), Nanoparticle-Based Drug Delivery (6 papers) and Advanced MRI Techniques and Applications (5 papers). The work is most often cited by research in Biomaterials (283 citations), Immunology and Allergy (111 citations) and Oncology (438 citations). Sandra T. van Tiel has collaborated with scholars based in Netherlands, Belgium and Spain. Frequent co-authors include Timo L.M. ten Hagen, Ann L.B. Seynhaeve, A.M.M. Eggermont, Johannes H. W. de Wilt, Alexander M.M. Eggermont, E. A. de Bruijn, Alexander Eggermont, Monique R. Bernsen, A.H. van der Veen and Saske Hoving. Their work appears in journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact